news
« BACK
Health - Life Sciences - 02.07.2020 
How the body fights off urinary tract infections
Some people are better protected than others against urinary tract infections. This may be because their bodies produce more of a protein called uromodulin. An interdisciplinary research team has now found out how this helper protein brings relief when nature calls and how this knowledge might benefit the treatment and prevention of these painful inflammations.
Environment - Health - 25.06.2020 
Towards a Swiss Food Strategy for 2050
NRP 69 recommends that the government develop a Swiss Food Strategy for 2050. This strategy should enable the entire population to eat healthy food sourced from a sustainable production and distribution system. Is it possible to follow a healthy diet that includes more vegetables, fruit and nuts while still reducing the environmental impact that consumption has both in Switzerland and abroad? Funded by the Swiss National Science Foundation (SNSF), the National Research Programme "Healthy Eating and Sustainable Food Production" (NRP 69) believes it is.
Health - Computer Science - 24.06.2020 
Swiss federal government officially launches the SwissCovid app
SwissCovid - a tracing app developed in part by EPFL - is being made available today to the general public, one month after the pilot tests began. The app will be a useful tool in stemming the spread of the disease as the number of cases in Switzerland is back on the rise. The World Health Organization was clear in its warning: the COVID-19 pandemic is not over, and in some places it's just as strong as ever.
Health - Computer Science - 24.06.2020
Health - 11.06.2020
Materials Science - Health - 09.06.2020 
First transparent surgical mask goes into production
Scientists of Empa and EPFL have developed a fully transparent surgical mask that will soon be produced on an industrial scale.
Life Sciences - Health - 09.06.2020 
RedHUMAN: Deciphering links between genes and metabolism
Scientists at EPFL have developed a new method that simplifies the processing of genetic-metabolic data by picking up changes in metabolism, a hallmark of numerous diseases like cancer and Alzheimer's. The new method, named redHUMAN, is robust and features guaranteed predictability. In the last two decades, the life sciences have seen a growing partnership with information technology.
Chemistry - Health - 08.06.2020
Chemistry - Health - 08.06.2020
Health - Pharmacology - 05.06.2020 
Gene therapy to reverse vision loss in macular degeneration
Researchers have developed a strategy that has the potential to improve vision in patients with macular degeneration in the future. Using a gene therapy, they sensitized blind retinas of mice and human organ donors to near-infrared light. The team based at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) has published its results .
Health - Life Sciences - 04.06.2020 
Deadly bacterial infection in pigs deciphered
New-born piglets often die painfully from infection with an intestinal bacterium. A team of researchers from 3 faculties at the University of Bern has now discovered how the bacterium causes fatal intestinal bleeding.
Life Sciences - Health - 03.06.2020 
How bacteria fertilise soya
Soya and clover have their very own fertiliser factories in their roots, where bacteria manufacture ammonium, which is crucial for plant growth. Although this has long been common knowledge, scientists have only recently described the mechanism in detail. With biotechnology, this knowledge could now help make agriculture more sustainable.
Health - Life Sciences - 02.06.2020
Materials Science - Health - 29.05.2020 
Wearable Health
There is more than cool looks about hip clothing for top performance: Thanks to a variety of smart technologies, high-tech clothing today is capable of analyzing body functions or actively optimizing the microclimate. The basis of these novel textiles are "smart" fibers and biocompatible composites that also contribute to innovations in biomedical research such as sensors, drug delivery systems or tissue engineering.
Electroengineering - Health - 28.05.2020 
Using electrical stimulus to regulate genes
A team of researchers has succeeded in using an electric current to directly control gene expression for the first time. Their work provides the basis for medical implants that can be switched on and off using electronic devices outside the body. This is how it works. A device containing insulin-producing cells and an electronic control unit is implanted in the body of a diabetic.
Health - Life Sciences - 28.05.2020 
Mapping Immune Cells in Brain Tumors
It is not always possible to completely remove malignant brain tumors by surgery so that further treatment is necessary. Researchers from the University of Zurich and the UniversityHospital Zurich have now been able to describe, with unparalleled precision, the composition of the immune cells of various types of brain tumors.
Health - Pharmacology - 28.05.2020 
Geneva study against SARS-CoV-2 gets underway
Geneva University Hospitals (HUG), the University of Geneva , the Infectious Disease Research Centre at Laval University in Quebec (Canada) and MaxiVAX - a Geneva-based company specialising in biotechnology - are working together to develop a SARS-CoV-2 vaccine. This joint research programme aims to create a vaccine combining an immunostimulator and a specific coronavirus target, namely the spike surface protein.
Health - Mathematics - 27.05.2020 
Estimating the second wave
ETH researchers are using a new mathematical model to calculate a possible second wave of the pandemic in Switzerland. Even though such a wave would probably grow more slowly than the first without overloading hospitals, its death toll may turn out to be significantly higher. Should Switzerland see a second wave of the coro rus pandemic, it would proceed more slowly than the first.
Health - Life Sciences - 26.05.2020 
Increased Usability and Precision in Vascular Imaging
Researchers at the University of Zurich have developed a new X-ray contrast agent. The contrast agent is easier to use and distributes into all blood vessels more reliably, increasing the precision of vascular imaging. This reduces the number of animals required in research experiments. Various diseases in humans and animals - such as tumors, strokes or chronic kidney disease - damage the blood vessels.
Life Sciences - Health - 25.05.2020
Health
Results 1 - 20 of 705.
Some people are better protected than others against urinary tract infections. This may be because their bodies produce more of a protein called uromodulin. An interdisciplinary research team has now found out how this helper protein brings relief when nature calls and how this knowledge might benefit the treatment and prevention of these painful inflammations.
NRP 69 recommends that the government develop a Swiss Food Strategy for 2050. This strategy should enable the entire population to eat healthy food sourced from a sustainable production and distribution system. Is it possible to follow a healthy diet that includes more vegetables, fruit and nuts while still reducing the environmental impact that consumption has both in Switzerland and abroad? Funded by the Swiss National Science Foundation (SNSF), the National Research Programme "Healthy Eating and Sustainable Food Production" (NRP 69) believes it is.
SwissCovid - a tracing app developed in part by EPFL - is being made available today to the general public, one month after the pilot tests began. The app will be a useful tool in stemming the spread of the disease as the number of cases in Switzerland is back on the rise. The World Health Organization was clear in its warning: the COVID-19 pandemic is not over, and in some places it's just as strong as ever.
Technology talent increasingly drawn to pharma industry since COVID-19, to solve healthcare challenges
83% of technology (tech) professionals would consider working in healthcare and pharma, with 72% more likely to consider it compared to six months ago 86% of tech professionals agree: the healthcare and pharma industry's "digital moment" has arrived Report includes insights from Microsoft, MIT and Benevolent AI on the powerful pairing of science and technology to reimagine medicine.
83% of technology (tech) professionals would consider working in healthcare and pharma, with 72% more likely to consider it compared to six months ago 86% of tech professionals agree: the healthcare and pharma industry's "digital moment" has arrived Report includes insights from Microsoft, MIT and Benevolent AI on the powerful pairing of science and technology to reimagine medicine.
Our sleep during lockdown: longer and more regular, but worse
A survey conducted by the University of Basel and the Psychiatric Hospital of the University of Basel has investigated how sleep has changed during the Covid-19 lockdown. The 435 individuals surveyed - most of whom were women - reported sleeping longer but with a deterioration in sleep quality. The results of the study were published in the scientific journal Current Biology.
A survey conducted by the University of Basel and the Psychiatric Hospital of the University of Basel has investigated how sleep has changed during the Covid-19 lockdown. The 435 individuals surveyed - most of whom were women - reported sleeping longer but with a deterioration in sleep quality. The results of the study were published in the scientific journal Current Biology.
Scientists of Empa and EPFL have developed a fully transparent surgical mask that will soon be produced on an industrial scale.
Scientists at EPFL have developed a new method that simplifies the processing of genetic-metabolic data by picking up changes in metabolism, a hallmark of numerous diseases like cancer and Alzheimer's. The new method, named redHUMAN, is robust and features guaranteed predictability. In the last two decades, the life sciences have seen a growing partnership with information technology.
Standardizing organoid growth through controlled guidance systems
A recent innovation from an EPFL laboratory will enable, for the first time, mass production of standardized organoids. This breakthrough was achieved thanks to a customized guidance system that ensures homogenous cell culturing. Described in an article published today in Nature Biomedical Engineering, the technique paves the way for industrial uses, such as screening new drugs.
A recent innovation from an EPFL laboratory will enable, for the first time, mass production of standardized organoids. This breakthrough was achieved thanks to a customized guidance system that ensures homogenous cell culturing. Described in an article published today in Nature Biomedical Engineering, the technique paves the way for industrial uses, such as screening new drugs.
Standardizing organoid growth through controlled cell culturing
A recent innovation from an EPFL laboratory will enable, for the first time, mass production of standardized organoids. This breakthrough was achieved thanks to a customized guidance system that ensures homogenous cell culturing. Described in an article published today in Nature Biomedical Engineering, the technique paves the way for industrial uses, such as screening new drugs.
A recent innovation from an EPFL laboratory will enable, for the first time, mass production of standardized organoids. This breakthrough was achieved thanks to a customized guidance system that ensures homogenous cell culturing. Described in an article published today in Nature Biomedical Engineering, the technique paves the way for industrial uses, such as screening new drugs.
Researchers have developed a strategy that has the potential to improve vision in patients with macular degeneration in the future. Using a gene therapy, they sensitized blind retinas of mice and human organ donors to near-infrared light. The team based at the Institute of Molecular and Clinical Ophthalmology Basel (IOB) has published its results .
New-born piglets often die painfully from infection with an intestinal bacterium. A team of researchers from 3 faculties at the University of Bern has now discovered how the bacterium causes fatal intestinal bleeding.
Soya and clover have their very own fertiliser factories in their roots, where bacteria manufacture ammonium, which is crucial for plant growth. Although this has long been common knowledge, scientists have only recently described the mechanism in detail. With biotechnology, this knowledge could now help make agriculture more sustainable.
A better model for neutrophil-related diseases
Neutrophils are critical immune cells for antimicrobial defense, but they can exacerbate a number of diseases, perhaps including COVID-19. The traditional approaches to study neutrophils in animal models are limited in specificity and effectiveness. EPFL scientists have now identified the problem and have developed a new, optimized model for studying the role of neutrophils in the context of disease.
Neutrophils are critical immune cells for antimicrobial defense, but they can exacerbate a number of diseases, perhaps including COVID-19. The traditional approaches to study neutrophils in animal models are limited in specificity and effectiveness. EPFL scientists have now identified the problem and have developed a new, optimized model for studying the role of neutrophils in the context of disease.
There is more than cool looks about hip clothing for top performance: Thanks to a variety of smart technologies, high-tech clothing today is capable of analyzing body functions or actively optimizing the microclimate. The basis of these novel textiles are "smart" fibers and biocompatible composites that also contribute to innovations in biomedical research such as sensors, drug delivery systems or tissue engineering.
A team of researchers has succeeded in using an electric current to directly control gene expression for the first time. Their work provides the basis for medical implants that can be switched on and off using electronic devices outside the body. This is how it works. A device containing insulin-producing cells and an electronic control unit is implanted in the body of a diabetic.
It is not always possible to completely remove malignant brain tumors by surgery so that further treatment is necessary. Researchers from the University of Zurich and the UniversityHospital Zurich have now been able to describe, with unparalleled precision, the composition of the immune cells of various types of brain tumors.
Geneva University Hospitals (HUG), the University of Geneva , the Infectious Disease Research Centre at Laval University in Quebec (Canada) and MaxiVAX - a Geneva-based company specialising in biotechnology - are working together to develop a SARS-CoV-2 vaccine. This joint research programme aims to create a vaccine combining an immunostimulator and a specific coronavirus target, namely the spike surface protein.
ETH researchers are using a new mathematical model to calculate a possible second wave of the pandemic in Switzerland. Even though such a wave would probably grow more slowly than the first without overloading hospitals, its death toll may turn out to be significantly higher. Should Switzerland see a second wave of the coro rus pandemic, it would proceed more slowly than the first.
Researchers at the University of Zurich have developed a new X-ray contrast agent. The contrast agent is easier to use and distributes into all blood vessels more reliably, increasing the precision of vascular imaging. This reduces the number of animals required in research experiments. Various diseases in humans and animals - such as tumors, strokes or chronic kidney disease - damage the blood vessels.
Even natural products can be harmful for the unborn child
Plant products ingested by pregnant women through their diet are broken down by the intestinal microbiota into chemical substances, some of which can cross the placental barrier and reach the fetus. These foreign substances can harm the unborn child, even if they are of "natural origin". Researchers at the Department for BioMedical Research (DBMR) at the University of Bern and Inselspital, University Hospital Bern, therefore warn against underestimating the effects of such substances.
Plant products ingested by pregnant women through their diet are broken down by the intestinal microbiota into chemical substances, some of which can cross the placental barrier and reach the fetus. These foreign substances can harm the unborn child, even if they are of "natural origin". Researchers at the Department for BioMedical Research (DBMR) at the University of Bern and Inselspital, University Hospital Bern, therefore warn against underestimating the effects of such substances.
